Electrolysis Technique vs Manual Therapy in Pelvic Pain

Sponsor
Quirón Madrid University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03163160
Collaborator
(none)
60
1
2
21.2
2.8

Study Details

Study Description

Brief Summary

Pelvic floor muscle physical therapy is recommended in clinical guidelines for women dyspareunia and pelvic pain. This study compare pelvic floor manual therapy and intratissue percutaneous electrolysis (EPI) technique in the treatment of pelvic pain in women with dyspareunia. Half of participants will receive pelvic floor manual therapy while the other half will receive intratissue percutaneous electrolysis technique.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pelvic floor manual therapy group
  • Procedure: Pelvic floor electrolysis group
N/A

Detailed Description

Dyspareunia is painful sexual intercourse and causes could be related to musculoskeletal pelvic floor muscles disorders (tenderness, trigger points, scars). There is evidence that manual therapy and intratissue percutaneous electrolysis can be effective for musculoskeletal pain disorders affecting muscles, tendons and fascias of the extremities but they have not been evaluated in pelvic floor muscle pain syndrome. The aim of this study is to compare manual therapy and EPI in the treatment of pelvic pain in women with dyspareunia.

Pelvic floor manual therapy is a clinical approach utilizing specifics hands-on mobilizing techniques to treat soft tissues. Pelvic floor mobilization is a slow controlled process of soft-tissue (myofascial) stretching intended to improve bio-mechanical elasticity.

EPI technique consists in an ultrasound-guided application of a galvanic electrolytic current that causes a controlled local inflammatory process in the target tissue. This allows for phagocytosis and the subsequent regeneration of the affected tissue.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Intratissue Percutaneous Electrolysis Technique vs. Manual Therapy in Women With Dyspareunia and Pelvic Pain
Actual Study Start Date :
Jun 20, 2017
Actual Primary Completion Date :
Mar 27, 2019
Actual Study Completion Date :
Mar 27, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pelvic floor manual therapy group

Pelvic floor manual therapy is a clinical approach utilizing specifics hands-on mobilizing techniques to treat soft tissues. The technique require mobilization of soft-tissue by myofascial stretching maneuvers intended to improve bio-mechanical elasticity. The therapeutic protocol will be applied for 4 weeks.

Procedure: Pelvic floor manual therapy group
Soft-tissue (myofascial) stretching techniques on pelvic floor muscles through external and internal (intra-vaginal) mobilizations. One weekly session for four weeks.
Other Names:
  • Man Ther Group
  • Experimental: Pelvic floor electrolysis group

    Pelvic floor electrolysis technique consists in an ultrasound-guided application of a galvanic electrolytic current that causes a controlled local inflammatory process in the target tissue. This allows for phagocytosis and the subsequent regeneration of the affected tissue. The therapeutic protocol will be applied for 4 weeks.

    Procedure: Pelvic floor electrolysis group
    An ultrasound-guided application of a galvanic electrolytic current with an acupuncture needle in the soft tissue of pelvic floor. EPI technique was applied using a specifically device (EPI-X Omega Advanced Medicine, Barcelona, Spain) which produces modulated galvanic electricity. This is applied using a modified electrosurgical scalpel that incorporates acupuncture needles (0.3 mm in diameter) of different lengths. The intensity can be adjusted by changing either the duration of stimulation or the output current (mA) of the device. One weekly session for four weeks.
    Other Names:
  • EPI
  • Outcome Measures

    Primary Outcome Measures

    1. Pain intensity before and after the intervention [Seven days after weekly session]

      Changes in pain intensity before and after the intervention. A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' current level of perineal pain during the external and intra-vaginal examination.

    Secondary Outcome Measures

    1. Female sexual function index [Seven days after the last session and three months later]

      Sexual function measure by the six-item Female Sexual Function Index (FSFI-6)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • women with pain in the perineal area at an average intensity of 5 or more on the Numerical Rating Scale (NRS) during penetration or during pelvic examination, which is indicative of moderate to severe pain

    • At least three months postpartum or any gynecology surgery

    Exclusion Criteria:
    • pregnancy

    • active urinary or vaginal infection

    • pelvic pathology associated with a lower genital pain problem (e.g. deep dyspareunia) and constant, spontaneous vulvar pain

    • younger than 18 or older than 65 years

    • previous interventions with steroid injections

    • fibromyalgia syndrome

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Universitario Quirón Madrid Madrid Spain 28223

    Sponsors and Collaborators

    • Quirón Madrid University Hospital

    Investigators

    • Principal Investigator: Carolina Walker, PT, PhD, Hospital Universitario Quiron Madrid

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Carolina Walker Chao, PhD, Quirón Madrid University Hospital
    ClinicalTrials.gov Identifier:
    NCT03163160
    Other Study ID Numbers:
    • BET116183
    First Posted:
    May 22, 2017
    Last Update Posted:
    Mar 28, 2019
    Last Verified:
    Mar 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Carolina Walker Chao, PhD, Quirón Madrid University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 28, 2019